SULFALAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfalar, and what generic alternatives are available?
Sulfalar is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in SULFALAR is sulfisoxazole. There is one drug master file entry for this compound. Additional details are available on the sulfisoxazole profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SULFALAR?
- What are the global sales for SULFALAR?
- What is Average Wholesale Price for SULFALAR?
Summary for SULFALAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 125 |
| Patent Applications: | 4,598 |
| DailyMed Link: | SULFALAR at DailyMed |
US Patents and Regulatory Information for SULFALAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | SULFALAR | sulfisoxazole | TABLET;ORAL | 084955-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
